The Alpha-fetoprotein (AFP) test is a crucial diagnostic tool that serves dual purposes in modern healthcare: detecting liver cancer and screening for birth defects during pregnancy. This comprehensive blood test measures AFP levels, a protein produced by the fetal liver and yolk sac, with abnormal concentrations indicating potential health concerns in both adults and developing babies. Understanding your AFP test results requires careful interpretation considering numerous clinical factors – which is exactly what our free AFP test calculator helps you accomplish.

In this definitive guide, you’ll discover:

• How AFP testing works and why it’s performed
• Normal AFP ranges for different populations and conditions
• The relationship between elevated AFP and liver cancer
• How AFP screening detects neural tube defects in pregnancy
• Factors that can affect AFP test results
• When to seek further medical evaluation
• How to use our free AFP test calculator
• Latest advancements in AFP testing methodologies

Read More Guide & Try Free Tools:

• Read our guide on: RDW Blood Test High: Anemia And Nutritional Deficiencies
• Read our guide on: Alkaline Phosphatase Levels: Bone And Liver Health Marker
• Read our guide on: CRP High Sensitivity: Cardiovascular Inflammation Risk

What is Alpha-fetoprotein (AFP) and Why is it Important?

Alpha-fetoprotein is a plasma protein produced primarily by the fetal liver and yolk sac during development. In healthy adults, AFP levels remain extremely low, but certain conditions can trigger increased production. The AFP blood test serves as both a tumor marker for hepatocellular carcinoma (HCC) and a screening tool for fetal abnormalities during pregnancy. Medical professionals worldwide rely on this test because it provides valuable diagnostic information through a simple blood draw, making it accessible and relatively non-invasive.

The importance of AFP testing spans multiple medical specialties:

• Oncology: Hepatocellular carcinoma detection and monitoring
• Obstetrics: Fetal anomaly screening
• Gastroenterology: Liver disease assessment
• Reproductive medicine: High-risk pregnancy management

At Doseway, we recognize the importance of accessible diagnostic interpretation, which is why we’ve developed comprehensive lab tests at home services that include AFP testing with professional interpretation.

How Does the Alpha-fetoprotein Test Work?

The AFP test measures the concentration of alpha-fetoprotein in a blood sample using immunoassay techniques. When performed for cancer screening, elevated AFP levels may indicate liver cancer or other malignancies. During pregnancy, abnormal AFP levels can signal potential birth defects or pregnancy complications. The test requires only a blood sample, typically drawn from a vein in the arm, and results are usually available within 1-3 days depending on the laboratory.

The biochemical process involves:

• Blood sample collection in appropriate tubes
• Serum separation through centrifugation
• Application of enzyme-linked immunosorbent assay (ELISA)
• Quantitative measurement in nanograms per milliliter (ng/mL)
• Interpretation based on established reference ranges

For those needing testing, Doseway offers convenient lab tests at home with certified technicians who ensure proper sample collection and handling.

What Are the Main Reasons Doctors Order AFP Tests?

Medical professionals order AFP tests for several specific clinical indications. Understanding these reasons helps patients comprehend their diagnostic journey and the importance of test results. The test serves different purposes depending on the patient population and clinical context.

The primary indications include:

• Liver cancer screening in high-risk patients (cirrhosis, chronic hepatitis B or C)
• Monitoring treatment response in known hepatocellular carcinoma
• Detecting cancer recurrence after liver cancer treatment
• Pregnancy screening between 15-20 weeks gestation
• Evaluating suspected neural tube defects like spina bifida
• Assessing risk of chromosomal abnormalities including Down syndrome
• Diagnosing and monitoring germ cell tumors of ovaries or testes

If your doctor has recommended an AFP test, you can easily book a lab test through our platform at Doseway and have a certified technician visit your location for sample collection.

What Constitutes Normal AFP Levels in Adults?

In healthy non-pregnant adults, normal AFP levels typically range from 0 to 10 ng/mL. Values exceeding this range warrant further investigation, though mild elevations can occur in benign liver conditions. The interpretation of “normal” varies slightly between laboratories due to differences in testing methodologies and reference populations. For cancer detection, most guidelines consider levels above 20 ng/mL as clinically significant, though this threshold may be lower for high-risk patients with chronic liver disease.

Key facts about normal AFP ranges:

• Adult males: 0-10 ng/mL
• Adult females (non-pregnant): 0-10 ng/mL
• Chronic liver disease patients: Levels up to 20 ng/mL may not indicate cancer
• Post-treatment cancer patients: Rising levels may indicate recurrence

Our free AFP test calculator incorporates these variables to help you understand where your results fall within expected ranges.

How Are AFP Levels Interpreted During Pregnancy?

Pregnancy represents a unique situation where AFP levels naturally elevate due to fetal production. Maternal serum AFP (MSAFP) screening typically occurs between 15-20 weeks gestation, with results interpreted based on precise gestational age. The test is usually part of the quadruple screen that also measures hCG, estriol, and inhibin-A. Proper interpretation requires accurate dating, often confirmed by ultrasound, as levels change rapidly throughout pregnancy.

Expected AFP ranges during pregnancy:

Gestational Age	Typical AFP Range
15 weeks	10-30 ng/mL
16 weeks	15-40 ng/mL
17 weeks	20-50 ng/mL
18 weeks	25-65 ng/mL
19 weeks	30-80 ng/mL
20 weeks	35-100 ng/mL

Elevated MSAFP may indicate:

• Neural tube defects (spina bifida, anencephaly)
• Abdominal wall defects (gastroschisis, omphalocele)
• Multiple gestation
• Underestimated gestational age
• Fetal demise

Low MSAFP may suggest:

• Down syndrome (trisomy 21)
• Edwards syndrome (trisomy 18)
• Overestimated gestational age
• Molar pregnancy

For expectant mothers with concerning AFP results, Doseway offers online doctor consultation with maternal-fetal medicine specialists who can provide expert guidance.

What is the Relationship Between AFP and Liver Cancer?

Hepatocellular carcinoma (HCC), the most common primary liver cancer, frequently produces elevated AFP levels. While not all liver cancers secrete AFP, approximately 60-70% of HCC patients show elevated levels, making it a valuable tumor marker. The degree of elevation often correlates with tumor burden, though some advanced cancers may not produce significant AFP. For patients with chronic liver disease, serial AFP measurements can detect cancer development at earlier, more treatable stages.

The clinical utility of AFP in liver cancer includes:

• Screening in high-risk populations
• Diagnosis when combined with imaging
• Prognostic information (higher levels often indicate worse outcomes)
• Treatment monitoring (declining levels suggest response)
• Surveillance for recurrence after treatment

It’s important to note that mildly elevated AFP (10-20 ng/mL) is common in chronic liver disease without cancer, particularly during periods of active inflammation or regeneration. Values exceeding 200 ng/mL in a patient with cirrhosis are highly suggestive of HCC, with specificity exceeding 95%, though biopsy confirmation is often still required.

Patients concerned about liver health can access comprehensive screening through Doseway‘s health services at your doorstep, including imaging and specialist consultations when needed.

What Other Cancers Can Cause Elevated AFP Levels?

While hepatocellular carcinoma is the most common malignancy associated with elevated AFP, several other cancers can produce this protein. Understanding the full spectrum of AFP-producing tumors ensures proper diagnostic evaluation when elevated levels are detected unexpectedly.

Non-liver cancers that may elevate AFP include:

• Germ cell tumors of ovaries and testes
• Yolk sac tumors (endodermal sinus tumors)
• Embryonal carcinoma components in mixed germ cell tumors
• Hepatoblastoma in children
• Rare gastric cancers with hepatoid differentiation
• Pancreaticobiliary cancers in uncommon cases
• Lung cancers with specific histological features

The pattern of AFP elevation and rate of increase often provides diagnostic clues. For example, very high AFP levels (exceeding 1000 ng/mL) are typical of germ cell tumors rather than HCC. When cancer is suspected based on AFP results, comprehensive evaluation through Doseway‘s online doctor consultation service can help determine appropriate next steps in the diagnostic process.

What Non-Cancerous Conditions Elevate AFP Levels?

Many benign conditions can cause mild to moderate AFP elevations, creating diagnostic challenges. Recognizing these non-malignant causes prevents unnecessary anxiety and inappropriate testing when elevated AFP is detected incidentally.

Common non-cancerous causes of elevated AFP:

• Chronic viral hepatitis (B or C)
• Alcoholic liver disease and cirrhosis
• Non-alcoholic fatty liver disease (NAFLD)
• Liver regeneration after injury or partial resection
• Acute hepatic necrosis from toxins or medications
• Ataxia-telangiectasia (genetic disorder)
• Tyrosinemia (hereditary metabolic disorder)
• Pregnancy (as expected physiological response)

In chronic liver disease, AFP levels may fluctuate with disease activity, often increasing during flares of inflammation and decreasing with treatment. Persistent mild elevations (typically <50 ng/mL) in stable cirrhosis usually don’t indicate cancer but warrant continued surveillance. Our free AFP test calculator helps distinguish between concerning and likely benign elevations based on your complete clinical picture.

How Does the AFP Test Fit into Liver Cancer Screening Protocols?

For individuals at high risk of developing hepatocellular carcinoma, regular surveillance with AFP and ultrasound represents the standard of care. Major liver societies recommend this approach because early detection significantly improves treatment outcomes and survival. The screening strategy must be tailored to individual risk factors and implemented consistently to be effective.

High-risk populations who benefit from AFP screening:

• Cirrhosis from any cause (viral, alcoholic, metabolic)
• Chronic hepatitis B infection (even without cirrhosis)
• Family history of hepatocellular carcinoma
• Certain genetic conditions (hemochromatosis, alpha-1-antitrypsin deficiency)
• Non-alcoholic steatohepatitis (NASH) with advanced fibrosis

Optimal screening intervals:

• Ultrasound + AFP every 6 months for most high-risk patients
• More frequent monitoring for those with suspicious but inconclusive findings
• Consider CT or MRI for patients with suboptimal ultrasound visualization

Through Doseway‘s comprehensive health services, individuals at risk for liver cancer can establish appropriate surveillance schedules with reminders and convenient testing options.

What Factors Can Affect AFP Test Results?

Multiple biological and technical factors can influence AFP measurements, potentially leading to false positives or negatives. Understanding these variables helps clinicians interpret results accurately and avoid diagnostic errors.

Biological factors affecting AFP levels:

• Age: Neonates have high levels that decline rapidly
• Pregnancy: Gestational age critically impacts expected ranges
• Race: Some populations show slightly different baseline levels
• Liver function: Impaired clearance affects levels
• Tumor characteristics: Not all cancers produce AFP
• Multiple gestation: Twins/triplets increase MSAFP
• Maternal weight: Affects MSAFP concentration

Technical considerations:

• Assay methodology: Different kits have varying reference ranges
• Sample handling: Improper processing affects results
• Laboratory quality: Variation between testing facilities
• Interfering substances: Heterophile antibodies can cause false elevations

Our free AFP test calculator accounts for many of these variables to provide more personalized interpretation of your results.

How Accurate is the AFP Test for Liver Cancer Detection?

The diagnostic accuracy of AFP for hepatocellular carcinoma has been extensively studied, with sensitivity and specificity varying based on the cutoff value used and the patient population. While AFP alone has limitations, it remains valuable when combined with imaging and clinical assessment.

Performance characteristics of AFP for HCC detection:

• Sensitivity: 40-65% at 20 ng/mL cutoff
• Specificity: 80-95% at 20 ng/mL cutoff
• Positive predictive value: Higher in high-prevalence populations
• Negative predictive value: Excellent when combined with ultrasound

Recent advancements have improved AFP utility:

• AFP-L3 fraction: More specific for malignant transformation
• PIVKA-II (DCP): Complementary marker with different sensitivity profile
• GALAD score: Algorithm combining AFP, AFP-L3, DCP, age, and gender

For patients with indeterminate results, Doseway facilitates online doctor consultation with hepatologists who can interpret complex diagnostic scenarios and recommend appropriate follow-up.

What is the Role of AFP in Pregnancy Screening Programs?

Maternal serum AFP screening represents one component of comprehensive prenatal testing designed to identify pregnancies at increased risk for specific fetal abnormalities. When integrated with other markers and ultrasound findings, MSAFP significantly improves detection rates for neural tube defects and chromosomal abnormalities.

Key aspects of AFP in prenatal screening:

• Optimal timing: 16-18 weeks gestation
• Detection rate for NTDs: 80-90% for open defects
• Detection rate for Down syndrome: 75-80% when combined with other markers
• False positive rate: Approximately 5% with proper dating
• Follow-up for positive screens: Detailed ultrasound and possibly amniocentesis

The screening process typically involves:

1. Blood draw for quadruple marker screen
2. Accurate gestational dating (ultrasound preferred)
3. Risk calculation adjusted for maternal factors
4. Result interpretation as screen positive/negative
5. Appropriate follow-up for screen-positive cases

Expectant parents with questions about prenatal testing can benefit from Doseway‘s online doctor consultation with obstetricians who specialize in prenatal diagnosis.

How Should Patients Prepare for an AFP Test?

Proper preparation for AFP testing ensures accurate results and minimizes the need for repeat testing. While requirements vary slightly between laboratories, general guidelines apply to most clinical scenarios.

Standard preparation instructions:

• Fasting: Usually not required unless ordered with other tests
• Medications: Continue unless specifically instructed otherwise
• Timing: Critical for pregnancy screening (15-20 weeks)
• Information needed: Accurate gestational age for pregnancy tests
• Previous results: Helpful for interpretation in monitoring situations

For therapeutic drug monitoring or specific scenarios:

• Consistent timing relative to treatment cycles
• Documentation of clinical status and symptoms
• Correlation with imaging findings when applicable

Through Doseway‘s lab tests at home service, patients receive clear preparation instructions and have support available for any questions before testing.

What Follow-up is Needed After an Abnormal AFP Result?

Abnormal AFP results require careful evaluation to determine clinical significance and appropriate next steps. The specific follow-up depends on the reason for testing, the degree of abnormality, and the patient’s overall clinical context.

Follow-up algorithms for elevated AFP:

For liver cancer screening:

• Repeat testing in 1-3 months for mild elevations
• Cross-sectional imaging (CT or MRI) for significant elevations
• Consider biopsy for suspicious lesions
• Hepatology consultation for persistent abnormalities

For pregnancy screening:

• Confirm gestational dating with ultrasound
• Detailed anatomical survey for structural defects
• Amniocentesis with AFP measurement in amniotic fluid
• Genetic counseling for abnormal results
• Maternal-fetal medicine consultation

For cancer monitoring:

• Repeat testing to confirm trend
• Imaging studies to assess disease status
• Treatment modification if indicated
• Multidisciplinary tumor board review

Doseway provides seamless coordination of follow-up care through our network of specialists and diagnostic facilities, ensuring patients receive appropriate evaluation without unnecessary delays.

What Are the Limitations of AFP Testing?

While valuable in appropriate clinical contexts, AFP testing has several important limitations that clinicians must consider when interpreting results. Understanding these constraints prevents overreliance on a single marker and promotes comprehensive patient assessment.

Key limitations of AFP testing:

• Not all cancers produce AFP: 30-40% of HCC cases have normal levels
• Non-specific elevations: Many benign conditions increase AFP
• Variable cutoff values: No universal threshold for malignancy
• Population differences: Optimal cutoffs vary by etiology of liver disease
• Technical variability: Results differ between laboratories
• Limited prognostic value: Except at extreme elevations
• Complementary markers needed: For adequate sensitivity

Clinical scenarios where AFP has reduced utility:

• Early-stage HCC: Often has normal or minimally elevated AFP
• Fibrolamellar HCC: Typically produces normal AFP
• Non-HCC liver tumors: Usually not AFP-producing
• Certain germ cell tumors: May not secrete AFP

Our free AFP test calculator addresses these limitations by incorporating clinical context and explaining the probabilistic nature of AFP interpretation.

How Has AFP Testing Evolved in Recent Years?

AFP testing methodologies and applications have advanced significantly, improving diagnostic accuracy and clinical utility. These developments reflect ongoing research into optimal cancer detection strategies and prenatal screening protocols.

Recent advancements in AFP testing:

• Automated immunoassays: Faster results with improved precision
• AFP-L3 percentage: Enhanced specificity for hepatocellular carcinoma
• Combination biomarker panels: Improved sensitivity for early detection
• Standardized reporting: Better consistency between laboratories
• Risk-adjusted interpretation: Algorithms incorporating clinical factors
• Point-of-care testing: Emerging technologies for rapid assessment

Future directions:

• Liquid biopsy applications: Combining AFP with circulating tumor DNA
• Artificial intelligence: Enhanced pattern recognition in biomarker profiles
• Novel isoforms: Identification of additional clinically relevant variants
• Personalized thresholds: Based on individual patient characteristics

Doseway stays current with these developments to ensure our lab tests at home services incorporate the most accurate and clinically relevant testing methodologies available.

What Are the Latest Guidelines for AFP Testing in Hepatocellular Carcinoma Surveillance?

Major professional societies periodically update recommendations for HCC surveillance, reflecting evolving evidence regarding optimal testing strategies. Current guidelines emphasize balanced approaches that maximize early detection while minimizing unnecessary testing and false positives.

Key recommendations from recent guidelines:

• American Association for Study of Liver Diseases (AASLD):
  Ultrasound with or without AFP every 6 months for high-risk patients
  Consider AFP alone if ultrasound inadequate
  MRI or CT for surveillance in specific high-risk scenarios
• European Association for Study of the Liver (EASL):
  Ultrasound every 6 months as primary surveillance
  AFP measurement as complementary test
  Shorter intervals (3-4 months) for very high-risk patients
• Asian Pacific Association for Study of the Liver (APASL):
  Ultrasound + AFP every 6 months preferred
  Lower AFP thresholds in hepatitis B carriers
  Consider additional biomarkers in high-prevalence regions

These guidelines generally agree on core principles while allowing flexibility for regional variations in resources and disease prevalence. Through Doseway‘s online doctor consultation, patients can receive personalized surveillance recommendations based on current guidelines and individual risk factors.

How Can Patients Access AFP Testing and Interpretation?

Access to AFP testing varies by healthcare system, but multiple pathways exist for patients needing this important diagnostic evaluation. Understanding these options helps ensure appropriate testing and interpretation.

Routes for AFP testing:

• Primary care physician referral: Traditional pathway for indicated testing
• Specialist ordered: Hepatologists, obstetricians, or oncologists
• Direct access testing: Available in some regions without physician order
• Screening programs: Organized surveillance for high-risk populations
• Research protocols: Investigational settings with specific criteria

Interpretation resources:

• Ordering physician: Primary interpreter of results
• Specialist consultation: For complex or abnormal findings
• Online tools: Like our free AFP test calculator
• Second opinion services: For confirmation of significant results

Doseway simplifies this process through integrated services that include testing, interpretation, and specialist follow-up when needed. Our health services at your doorstep bring comprehensive diagnostic evaluation to your preferred location.

How to Use the Free AFP Test Calculator

Our free AFP test calculator provides personalized interpretation of your alpha-fetoprotein results based on your specific clinical context. This tool incorporates established medical guidelines while accounting for individual factors that affect AFP levels and their significance.

Step-by-step guide to using the calculator:

1. Enter demographic information: Age, gender, and clinical context
2. Input medical history: Liver conditions, pregnancy status, and risk factors
3. Provide AFP test results: Including units and testing circumstances
4. Review calculation: Color-coded risk assessment with explanation
5. Access recommendations: Personalized next steps based on results

The calculator considers:

• Age-adjusted reference ranges
• Pregnancy-specific interpretations
• Liver disease context
• Cancer risk factors
• Technical factors affecting results

For complex cases or concerning results, the calculator recommends appropriate follow-up, including online doctor consultation through Doseway for professional medical advice.

What Additional Testing Might Be Needed After an Abnormal AFP?

Abnormal AFP results often require additional evaluation to determine clinical significance and guide management. The specific follow-up tests depend on the initial reason for AFP testing and the degree of abnormality.

Diagnostic pathways after abnormal AFP:

For possible liver cancer:

• Cross-sectional imaging: Multiphasic CT or contrast-enhanced MRI
• Liver biopsy: Histological confirmation when imaging inconclusive
• Additional biomarkers: AFP-L3, PIVKA-II, or GALAD score
• Monitoring: Repeat AFP and imaging at shorter intervals

For pregnancy screening abnormalities:

• Targeted ultrasound: Detailed anatomical survey
• Amniocentesis: AFP and acetylcholinesterase in amniotic fluid
• Genetic testing: Chromosomal microarray or karyotype
• Fetal echocardiography: For suspected cardiac anomalies

For possible germ cell tumors:

• Testicular ultrasound: For men with elevated AFP
• Pelvic imaging: For women with elevated AFP
• Additional tumor markers: hCG, LDH, CA-125
• CT chest/abdomen/pelvis: Staging evaluation

Doseway coordinates comprehensive diagnostic evaluations through our network of imaging centers and specialists, ensuring appropriate follow-up for abnormal test results.

How Does AFP Testing Compare to Other Tumor Markers?

AFP represents one of many available tumor markers, each with specific strengths, limitations, and clinical applications. Understanding how AFP compares to other markers helps clinicians select appropriate testing strategies and interpret results in context.

Comparison of AFP with other common tumor markers:

Marker	Primary Cancers	Sensitivity	Specificity	Key Applications
AFP	HCC, germ cell	60-70%	80-90%	Liver cancer screening, prenatal screening
CEA	Colorectal, lung	40-70%	60-80%	Colorectal cancer monitoring
CA 19-9	Pancreatic, biliary	70-90%	80-90%	Pancreatic cancer diagnosis, monitoring
PSA	Prostate	70-90%	20-40%	Prostate cancer screening, monitoring
CA 125	Ovarian	80-90%	60-80%	Ovarian cancer monitoring

Unique advantages of AFP:

• Dual utility in oncology and obstetrics
• Established role in high-risk HCC surveillance
• Prognostic value at extreme elevations
• Standardized assays widely available

Through Doseway‘s comprehensive lab tests at home services, patients can access appropriate tumor marker testing based on their specific clinical situation with professional interpretation of results.

What is the Cost of AFP Testing and Insurance Coverage?

The cost of AFP testing varies based on healthcare system, testing indication, and insurance coverage. Understanding typical cost ranges and coverage policies helps patients anticipate potential out-of-pocket expenses.

Cost considerations for AFP testing:

• United States: $50-200 without insurance
• With insurance: Typically covered with copay for indicated testing
• Medicare: Covers for approved indications with specific frequency limits
• Medicaid: Coverage varies by state but generally includes medically necessary testing
• International: Wide variation by country and healthcare system

Insurance coverage generally requires:

• Appropriate clinical indication
• Physician order with supporting documentation
• In-network laboratory when applicable
• Pre-authorization for some plans and indications

Doseway offers transparent pricing for self-pay patients and assistance with insurance verification for those with coverage. Our online pharmacy also provides affordable medications for conditions identified through testing.

FAQs: People Also Ask About Alpha-fetoprotein Testing

What does a high AFP level mean in a non-pregnant woman?
In non-pregnant women, elevated AFP levels may indicate liver disease, liver cancer, or other malignancies such as germ cell tumors of the ovaries. Benign conditions like chronic hepatitis or cirrhosis can also cause mild to moderate elevations. Evaluation typically includes liver imaging and additional tests to determine the cause.

Can AFP levels be high without cancer?
Yes, AFP levels can elevate without cancer presence. Common non-cancerous causes include liver regeneration after injury, chronic hepatitis, cirrhosis, pregnancy, and certain genetic disorders. The degree of elevation and clinical context help distinguish between malignant and benign causes.

How often should AFP tests be done for liver cancer screening?
For high-risk individuals, most guidelines recommend AFP testing every 6 months alongside ultrasound. More frequent testing (every 3 months) may be appropriate for those with concerning but inconclusive findings or very high-risk profiles. Doseway‘s health services can help establish appropriate screening schedules.

What is the normal range for AFP in pregnancy?
Normal AFP ranges in pregnancy depend on gestational age, typically increasing until around 30 weeks then gradually declining. At 16-18 weeks (when screening is performed), levels usually range from 15-60 ng/mL. Our free AFP test calculator incorporates gestational age-specific ranges for accurate interpretation.

Can medications affect AFP test results?
Most medications don’t significantly affect AFP levels, though drugs that cause liver injury may indirectly increase AFP through hepatic regeneration. Cancer treatments targeting rapidly dividing cells typically decrease AFP levels in AFP-producing tumors. Always inform your doctor of all medications when interpreting AFP results.

How quickly do AFP levels change after liver cancer treatment?
AFP typically has a half-life of 5-7 days, so levels should decrease significantly within weeks of successful treatment. Persistent or rising levels after treatment may indicate residual or recurrent disease. Monitoring AFP trends provides important information about treatment response.

Does AFP level correlate with cancer stage?
In hepatocellular carcinoma, higher AFP levels often correlate with more advanced disease and larger tumor burden, though exceptions occur. Some early cancers produce significant AFP while some advanced tumors don’t secrete this marker. AFP is one of several factors considered in staging and prognosis.

Disclaimer

The information provided in this article is for educational purposes only and does not constitute medical advice. The AFP test calculator offers general guidance based on established medical knowledge but cannot replace professional medical evaluation. Always consult with a qualified healthcare provider for interpretation of test results and personalized medical recommendations.